Dr Dan Thomas is the leader of SAHMRI's Blood Cancer Program. Dr Thomas is both a clinical haematologist and pathologist whose goals in research are to develop new drugs for the treatment of rare blood cancers. His career was set up by 7 years of post-doctoral training at the Stanford School of Medicine under pre-eminent leaders of his field. The Thomas Lab has a strong track record in finding new druggable targets in cancer and predicting mutations that respond to specific targeted therapies as well as repurposing old drugs for new uses in cancer. Some of the discoveries that Dr Thomas has contributed to are already in the clinic or are under clinical investigation. Outside of work, Dr Thomas is a husband, and a father to his young son. He can often be found cycling, bushwalking, enjoying music, spending time on the farm and in his local church community.